A carregar...
Biomarkers and Targeted Therapy in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) constitutes 90% of pancreatic cancers. PDAC is a complex and devastating disease with only 1%–3% survival rate in five years after the second stage. Treatment of PDAC is complicated due to the tumor microenvironment, changing cell behaviors to the mesenchymal...
Na minha lista:
| Publicado no: | Biomark Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Libertas Academica
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847554/ https://ncbi.nlm.nih.gov/pubmed/27147897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BiC.s34414 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|